Cell-surface and secreted glycoproteins and glycolipids contribute to numerous interactions with the extracellular environment that influence cellular physiology and pathology 1,2. These interactions ...

Targeting therapeutic transgene expression to defined tissues is a major task in the development of safe and efficient gene therapy protocols. Recombinant adenovirus is an attractive vector because it ...

Escherichia coli is widely considered the most cost-effective bacterial system for recombinant protein expression. Consequently, it is broadly used. Nonetheless, it has its limitations as an ...

Viruses have evolved by borrowing and modifying cellular genes to become extremely efficient at nucleic acid delivery to different cell types, avoiding at the same time immunosurveillance by an ...

Our vector technology uniquely enables the delivered RNA payload to be persistently expressed for days without integrating into the cellular genomes. This improves upon the persistence of nonviral ...

WASHINGTON, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Recombinant DNA Technology Market finds that the increasing strategic collaborations among key ...

Circio Holding ASA has announced significant advancements in its circVec-AAV expression platform, showcasing a 50% boost in gene expression with its new circVec 4.0 construct. This development ...

Circio Holding ASA announced an upcoming webcast where CTO Dr. Thomas B Hansen will present the latest in vitro and in vivo results of their circVec circular RNA expression platform, highlighting its ...